Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting

Wang Xiao-ying; Miao Feng

doi:10.1007/BF02836519

Your Location：

Home >

Browse articles >

Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting

Updated：2021-08-27

- Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting
- Chinese Journal of Integrative Medicine Vol. 12, Issue 3, Pages: 185-188(2006)
- Affiliations：
  
  Hospital of Zhejiang University,Hangzhou
- Author bio：
- Funds：
- DOI：10.1007/BF02836519
  CLC：
- Published：2006，
Scan for full text
Xiao-ying, W., Feng, M. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting., Chin. J. Integr. Med. 12, 185–188 (2006). https://doi.org/10.1007/BF02836519

Wang Xiao-ying, Miao Feng. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting. [J]. Chinese Journal of Integrative Medicine 12(3):185-188(2006)
Xiao-ying, W., Feng, M. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting., Chin. J. Integr. Med. 12, 185–188 (2006). https://doi.org/10.1007/BF02836519 DOI：

Wang Xiao-ying, Miao Feng. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting. [J]. Chinese Journal of Integrative Medicine 12(3):185-188(2006) DOI： 10.1007/BF02836519.

摘要

Objective: To observe the levels of serum C-reactive protein (CRP)

endothelin-1 (ET-1)

nitric oxide (NO)

and superoxide dismutase (SOD) in patients after intracoronary stenting (ICS)

and the effects of Erigeron Injection (EI) on them.Methods: Seventy-two patients

who received ICS and had symptoms of chest stuffiness

palpitation and chest pain

were randomly divided into two groups

with 36 patients in the control group treated with Plavix alone for anti-platelet aggregation

and the other 36 patients in the treated group treated with Plavix and EI in combination. CRP

ET-1

NO and SOD were determined and compared before and 1

2 and 3 weeks after treatment.Results: As compared with those in the control group

improvement of symptoms in the treated group was significantly better

with the levels of CRP and ET-1 lower and levels of SOD and NO higher or approaching to normal ranges and significant difference was shown between the two groups (P < 0.01).Conclusion: EI could alleviate uncomfortable feelings such as chest stuffiness in patients after ICS

and improve the function of vascular endothelium.

Abstract

Objective: To observe the levels of serum C-reactive protein (CRP)

endothelin-1 (ET-1)

nitric oxide (NO)

and superoxide dismutase (SOD) in patients after intracoronary stenting (ICS)

and the effects of Erigeron Injection (EI) on them.Methods: Seventy-two patients

who received ICS and had symptoms of chest stuffiness

palpitation and chest pain

were randomly divided into two groups

with 36 patients in the control group treated with Plavix alone for anti-platelet aggregation

and the other 36 patients in the treated group treated with Plavix and EI in combination. CRP

ET-1

NO and SOD were determined and compared before and 1

2 and 3 weeks after treatment.Results: As compared with those in the control group

improvement of symptoms in the treated group was significantly better

and improve the function of vascular endothelium.

关键词

after intracoronary stentingendothelinC-reactive proteinsuperoxide dismutaseNitric OxideErigeron Injection

Keywords

after intracoronary stentingendothelinC-reactive proteinsuperoxide dismutaseNitric OxideErigeron Injection

references

State Administration of Traditional Chinese Medicine. Trade standard of Peoples Republic of China. 1995: 18–19.

Zhang MZ, Tian WJ, Zou X, et al. Thinking and method of TCM syndrome differentiation depending therapy before and after coronary invention treatment of acute myocardial infarction: analysis on treatment of 70 Patients. Chin J Integr Tradit West Med 2004;7(24): 638–639.

Yu AZ. Li JF, Li GS, et al. A clinical study on the minor myocardial injury associated with percutaneous coronary intervention. J Chin Phys 2004;5(5): 629–630.

Hu DY, Zhao MZ. Therapy level of coronary heart disease in our country. Chin J Pract Intern Med 2005;25 (1): 3–4.

Liu SY, Zhang H, Li YJ, et al. Protective effect and mechanism of Honghua Injection on myocardial ischemia during intervention treatment inpatients with coronary heart diseases. J Heibei Tradit Chin Med Pharmacol 2004;19(4): 29–31.

Ju Y. Significance and change of serum ET, TNF-α and NO in patients with coronary heart disease. Chin J Med Pract 2005;94(1): 122–123.

Zhang J, Li XS, Zhang WD. Progress on chemical ingredients and pharmacological activity of Chinese herbal Erigeronis. J Pharm Pract 2002;2: 156–157.

Shen L, Ji HF, Chai JG. Theoretical assessment on clearing activity of free radical by nine kinds of nature products. Acta Biophys Sin 2005;10(21): 333–335.

Zhong HJ, Deng YJ. Progress on new dosage form of Erigeronis. Chin Tradit Pat Med 2005; (8): 178–179.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Metabolic regulatory and anti-oxidative effects of modified bushen huoxue decoction (补肾活血方) on experimental rabbit model of osteoarthritis

Observation on clinical effect of acupuncture on superoxide dismutase, lipid peroxide and nitric oxide in vascular dementia patients

Observation of clinical effect of acupuncture on vascular dementia and its influence on superoxide dismutase, lipid peroxide and nitric oxide

Effect of Shengmai injection (生脉注射液) on diaphragmatic contractility in doxorubicin-treated rats

Related Author

No data

Related Institution

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Tianjin University of Traditional Chinese Medicine

Institute of Acupuncture, Guangzhou University of TCM

Hualan Teacher’s University

The First Affiliated Hospital of Guangzhou University of TCM

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰